Investors and Media


Partnering is a key component of Priavoid´s strategy

We are developing alliances with leading pharmaceutical and biotech companies around the world and are active in talking to potential new partners on our promising pipeline of novel CNS compounds.

Contact us

Please use our contact form if you require any information.

Cookie Preference

Please select an option. You can find more information about the consequences of your choice at Help.

Select an option to continue

Your selection was saved!



To continue, you must make a cookie selection. Below is an explanation of the different options and their meaning.

  • Accept all cookies:
    All cookies such as tracking and analytics cookies.
  • Accept first-party cookies only:
    Only cookies from this website.
  • Reject all cookies:
    No cookies except for those necessary for technical reasons are set.

You can change your cookie setting here anytime: Privacy Policy. Legal Notice